Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine



   glycogen storage disease ib
  

Disease ID 1420
Disease glycogen storage disease ib
Definition
Glycogen storage disease type I that is caused by mutations in the SLC37A4 gene. It is characterized by a deficiency of glucose-6-phosphate translocase. It may be associated with neutropenia resulting in recurrent bacterial infections, inflammatory bowel disease, gingivitis, periodontal disease, and mouth ulcers.
Synonym
glucose 6-phosphate transport defect
glucose-6-phosphate transport defect
glucose-6-phosphate transport defect (disorder)
glycogen storage disease type i non-a
glycogen storage disease type ib
gsd ib
gsd1b
OMIM
UMLS
C0268146
SNOMED-CT
Comorbidity
UMLS | Disease | Sentences' Count(Total Sentences:9)
C0027947  |  neutropenia  |  2
C0021390  |  inflammatory bowel disease  |  1
C0020617  |  hypoglycaemic coma  |  1
C0021831  |  bowel disease  |  1
C0030312  |  pancytopenia  |  1
C0020598  |  hypoglycaemia  |  1
C0023890  |  liver cirrhosis  |  1
C0023890  |  cirrhosis  |  1
C0002871  |  anemia  |  1
Curated Gene
Entrez_id | Symbol | Resource(Total Genes:2)
2538  |  G6PC  |  CLINVAR
2542  |  SLC37A4  |  CLINVAR;CTD_human;UNIPROT
Inferring Gene(Waiting for update.)
Text Mined Gene(Waiting for update.)
Locus(Waiting for update.)
Disease ID 1420
Disease glycogen storage disease ib
Integrated Phenotype
HPO | Name(Total Integrated Phenotypes:24)
HP:0002240  |  Enlarged liver
HP:0000105  |  Renal enlargement
HP:0000155  |  Oral ulcer
HP:0000823  |  Pubertal delay
HP:0000097  |  focal glomerulosclerosis
HP:0002910  |  Elevated transaminases
HP:0000093  |  Proteinuria
HP:0012213  |  Reduced creatinine clearance
HP:0001997  |  Gout
HP:0004322  |  Stature below 3rd percentile
HP:0000295  |  Doll-like facies
HP:0000822  |  Hypertension
HP:0001943  |  Hypoglycemia
HP:0001538  |  Protuberant abdomen
HP:0000991  |  Xanthomata
HP:0001402  |  Hepatocellular carcinoma
HP:0002718  |  Recurrent pyogenic infections
HP:0003128  |  Lactic acidosis
HP:0001733  |  Pancreatic inflammation
HP:0003077  |  Hyperlipidemia
HP:0000939  |  Osteoporosis
HP:0001875  |  Neutropenia
HP:0000787  |  Renal calculi
HP:0000660  |  Lipemia retinalis
Text Mined Phenotype
HPO | Name | Sentences' Count(Total Phenotypes:8)
HP:0001875  |  Neutropenia  |  2
HP:0001259  |  Coma  |  1
HP:0001903  |  Anemia  |  1
HP:0001325  |  Coma caused by low blood sugar  |  1
HP:0001433  |  Enlarged liver and spleen  |  1
HP:0001943  |  Hypoglycemia  |  1
HP:0001876  |  Low blood cell count  |  1
HP:0001394  |  Hepatic cirrhosis  |  1
Disease ID 1420
Disease glycogen storage disease ib
Manually Symptom
UMLS  | Name(Total Manually Symptoms:5)
C1963084  |  colitis
C1378703  |  renal carcinoma
C0272183  |  neutrophil dysfunction
C0027947  |  neutropenia
C0021390  |  inflammatory bowel disease
Text Mined Symptom
UMLS | Name | Sentences' Count(Total Symptoms:2)
Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)
Text Mining Genotype(Total Genotypes:0)
(Waiting for update.)
All Snps(Total Genotypes:60)
snpId pubmedId geneId geneSymbol diseaseId sourceId sentence score Year geneSymbol_dbSNP CHROMOSOME POS REF ALT
rs121908975NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119025251CT,A
rs121908976NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119028288CT
rs121908977NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119027016CAC-
rs121908978NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119029287CT
rs121908978100261672542SLC37A4umls:C0268146UNIPROTInactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b.0.4435287441999SLC37A411119029287CT
rs121908979NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119024957GA
rs121908980NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119025298CT
rs121908980109314212542SLC37A4umls:C0268146UNIPROTGlycogen storage disease type Ib without neutropenia.0.4435287442000SLC37A411119025298CT
rs1801175NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742903947CT
rs1801176NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742903948GA
rs193302877216295662542SLC37A4umls:C0268146UNIPROTA novel mutation in SLC37A4 gene in a Sri Lankan boy with glycogen storage disease type Ib associated with very early onset neutropenia.0.4435287442011SLC37A411119028426CT
rs193302878195797602542SLC37A4umls:C0268146UNIPROTGlycogen storage disease type Ib: the first case in Taiwan.0.4435287442009SLC37A411119026985AG
rs193302879159538772542SLC37A4umls:C0268146UNIPROTA novel mutation (A148V) in the glucose 6-phosphate translocase (SLC37A4) gene in a Korean patient with glycogen storage disease type 1b.0.4435287442005SLC37A411119027811GA
rs193302880104829622542SLC37A4umls:C0268146UNIPROTThe putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.0.4435287441999SLC37A411119026053GA
rs19330288197586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119029311CT
rs19330288297586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119029288GA
rs19330288397586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119027806CT
rs19330288497586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119028412TG
rs19330288597586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119028373CT
rs19330288697586262542SLC37A4umls:C0268146UNIPROTA gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic.0.4435287441998SLC37A411119028312CT
rs193302887NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119029300AG
rs193302887124092732542SLC37A4umls:C0268146UNIPROTNovel missense mutation (Y24H) in the G6PT1 gene causing glycogen storage disease type 1b.0.4435287442002SLC37A411119029300AG
rs193302888NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119027681GA
rs193302888108743222542SLC37A4umls:C0268146UNIPROTA novel missense mutation (P191L) in the glucose-6-phosphate translocase gene identified in a Chinese family with glycogen storage disease 1b.0.4435287442000SLC37A411119027681GA
rs193302889109230422542SLC37A4umls:C0268146UNIPROTMolecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients.0.4435287442000SLC37A411119029289AT
rs193302890109230422542SLC37A4umls:C0268146UNIPROTMolecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients.0.4435287442000SLC37A411119027796GA
rs193302891109230422542SLC37A4umls:C0268146UNIPROTMolecular analysis in glycogen storage disease 1 non-A: DHPLC detection of the highly prevalent exon 8 mutations of the G6PT1 gene in German patients.0.4435287442000SLC37A411119026049TG
rs193302892NA2542SLC37A4umls:C0268146UNIPROTNA0.443528744NASLC37A411119027808CT
rs193302893104829622542SLC37A4umls:C0268146UNIPROTThe putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.0.4435287441999SLC37A411119027706AG
rs193302894104829622542SLC37A4umls:C0268146UNIPROTThe putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.0.4435287441999SLC37A411119029222CG
rs193302895104829622542SLC37A4umls:C0268146UNIPROTThe putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a.0.4435287441999SLC37A411119027728AG
rs193302898110713912542SLC37A4umls:C0268146UNIPROTMutation analysis in glycogen storage disease type 1 non-a.0.4435287442000SLC37A411119028413GT
rs193302899119499312542SLC37A4umls:C0268146UNIPROTType I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.0.4435287442002SLC37A411119028321AG
rs193302900119499312542SLC37A4umls:C0268146UNIPROTType I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.0.4435287442002SLC37A411119026640AT
rs193302900NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119026640AT
rs193302901119499312542SLC37A4umls:C0268146UNIPROTType I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.0.4435287442002SLC37A411119025196GT,C
rs193302902156696772542SLC37A4umls:C0268146UNIPROTAllelic heterogeneity of glycogen storage disease type Ib in French patients: a study of 11 cases.0.4435287442004SLC37A411119027035AG
rs19330290397816882542SLC37A4umls:C0268146UNIPROTStructure and mutation analysis of the glycogen storage disease type 1b gene.0.4435287441998SLC37A411119026052CT
rs551439289NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119027069GA
rs606231368NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742907561-AT
rs781784543NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119026979GA
rs786204477NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119026016-TCATGCCAGCCA
rs786204637NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119028193CT
rs786204740NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119029369TC
rs80356479NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742900955C-
rs80356482NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742909418GA,C
rs80356483NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742911161GT
rs80356484NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742911000GT
rs80356485NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742911076CT
rs80356486NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742911331TTC-
rs80356487NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742911391CG,T
rs80356488NA2538G6PCumls:C0268146CLINVARNA0.122714419NAG6PC1742907562-TA
rs80356489104828752542SLC37A4umls:C0268146UNIPROTGlycogen storage disease type Ib: structural and mutational analysis of the microsomal glucose-6-phosphate transporter gene.0.4435287441999SLC37A411119028223AG
rs80356489NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119028223AG
rs80356489150596222542SLC37A4umls:C0268146BeFreeGenetic testing of glycogen storage disease type Ib in Japan: five novel G6PT1 mutations and a rapid detection method for a prevalent mutation W118R.0.4435287442004SLC37A411119028223AG
rs80356490NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119025299CA
rs8035649094286412542SLC37A4umls:C0268146UNIPROTSequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib.0.4435287441997SLC37A411119025299CA
rs80356491NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119025271AG-
rs80356492105180302542SLC37A4umls:C0268146UNIPROTMutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c.0.4435287441999SLC37A411119025215CT
rs80356492NA2542SLC37A4umls:C0268146CLINVARNA0.443528744NASLC37A411119025215CT
GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)
GWASdb Snp Trait(Total Genotypes:0)
(Waiting for update.)
Mapped by lexical matching(Total Items:6)
HP ID HP Name MP ID MP Name Annotation
HP:0003128Lactic acidosisMP:0003031acidosisa pathological state characterized by an increase in the hydrogen ion concentration in tissues and blood caused by an decrease in the concentration of alkaline compounds, or by a increase in the concentration of acidic compounds or carbon dioxide to the b
HP:0000097Focal segmental glomerulosclerosisMP:0005264glomerulosclerosishyaline deposits or scarring within the renal glomeruli, often occurring with renal arteriosclerosis or diabetes
HP:0002910Elevated hepatic transaminasesMP:0002628hepatic steatosisan accumulation of fat deposits in the liver
HP:0001402Hepatocellular carcinomaMP:0010367increased spindle cell carcinoma incidencegreater than the expected number of a highly malignant variant of squamous cell carcinoma, occurring in a specific population in a given time period; spindle cell carcinoma shows biphasic proliferation of conventional SCC component and malignant spindle s
HP:0002718Recurrent bacterial infectionsMP:0009788increased susceptibility to bacterial infection induced morbidity/mortalityincreased likelihood that an organism will display the expected moribund state caused by a bacterial invasion or from components of or toxins produced by bacteria
HP:0001538Protuberant abdomenMP:0001270distended abdomenabdomen appears curved outward or swollen
Mapped by homologous gene(Total Items:24)
HP ID HP Name MP ID MP Name Annotation
HP:0003077HyperlipidemiaMP:0020216decreased circulating complement protein levelless than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes
HP:0000097Focal segmental glomerulosclerosisMP:0013310abnormal adrenal gland developmentaberrant formation or incomplete differentiation of the pair of endocrine glands located above the kidney that are responsible for steroid hormone secretion from the cortex and neurotransmitter (such as epinephrine and norepinephrine) secretion from the m
HP:0000105Enlarged kidneysMP:0013723increased circulating tyrosine levelthe amount of the amino acid histidine in the blood is more than expected
HP:0004322Short statureMP:3000003abnormal Ebner's gland morphologyany structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l
HP:0002240HepatomegalyMP:0020329decreased capillary densityreduction in the number of capillaries in a given cross-sectional area of a tissue
HP:0000295Doll-like faciesMP:0011363renal glomerulus atrophyacquired diminution of the size of the capillary loops of the kidney associated with wasting as from death and reabsorbtion of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfu
HP:0000991XanthomatosisMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0000093ProteinuriaMP:0020216decreased circulating complement protein levelless than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes
HP:0000939OsteoporosisMP:0020254decreased collagen leveldecreased level of the main structural protein of the various connective tissues in animals
HP:0003128Lactic acidosisMP:0020214susceptible to malignant hyperthermiaincreased susceptibility to hyperthermia triggered by exposure to certain drugs used for general anesthesia, specifically the volatile anesthetic agents and the neuromuscular blocking agent, succinylcholine
HP:0001997GoutMP:0020234decreased basal metabolismdecrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state
HP:0002910Elevated hepatic transaminasesMP:0020234decreased basal metabolismdecrease in heat production of an organism at the lowest level of cell chemistry in an inactive, awake, and fasting state
HP:0001943HypoglycemiaMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0000155Oral ulcerMP:0020154impaired humoral immune responseimpaired response of the immune system that mediates secreted antibodies produced in B cells
HP:0012213Decreased glomerular filtration rateMP:0011363renal glomerulus atrophyacquired diminution of the size of the capillary loops of the kidney associated with wasting as from death and reabsorbtion of cells, diminished cellular proliferation, decreased cellular volume, pressure, ischemia, malnutrition, reduced function or malfu
HP:0000787NephrolithiasisMP:0020316decreased vascular endothelial cell proliferationdecrease in the expansion rate of any vascular endothelial cell population by cell division
HP:0001402Hepatocellular carcinomaMP:0013745abnormal eyelid margin morphologyany structural anomaly of the confluence of the mucosal surface of the conjunctiva, the edge of the orbicularis, and the cutaneous epithelium
HP:0000823Delayed pubertyMP:0020087increased susceptibility to non-insulin-dependent diabetesincreased likelihood to develop non-insulin-dependent diabetes
HP:0000660Lipemia retinalisMP:0011582decreased triglyceride lipase activityreduced ability to catalyze the reaction: triacylglycerol + H2O = diacylglycerol + a fatty acid anion
HP:0001875NeutropeniaMP:0020215impaired blood coagulationimpaired ability of the blood to clot
HP:0002718Recurrent bacterial infectionsMP:0020216decreased circulating complement protein levelless than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes
HP:0001733PancreatitisMP:0020134abnormal gallbladder sizean anomaly in the size of the gall bladder compared to average, the organ that serves as a storage reservoir for bile
HP:0001538Protuberant abdomenMP:0020137decreased bone mineralizationdecrease in the rate at which minerals are deposited into bone
HP:0000822HypertensionMP:0020216decreased circulating complement protein levelless than normal levels of the serum proteins that act sequentially to allow for the direct killing of microbes, the disposal of immune complexes, and the regulation of other immune processes
Disease ID 1420
Disease glycogen storage disease ib
Case(Waiting for update.)